Today, NORML and it’s national network of advocacy chapters released a memo to state lawmakers, regulators, prosecutors, and other interested parties providing guidance for how they can take emergency actions to better promote the health and welfare of cannabis consumers and the general public during the COVID pandemic.
“Claims about the benefits of using CBD on viral infections were largely supported by CBD online retailers and most often appear to be a biased interpretation of the scientific literature or a dishonest manipulation of the information for commercial purposes.”
A majority of Americans agree with states’ decisions to classify licensed medical cannabis facilities as “essential services” to the community – a designation that permits them to maintain retail operations during regional ‘stay-at-home’ orders.
“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”